Coenzyme Q10 (CoQ10) 组成电子传递链,并参与细胞有氧呼吸.
Coenzyme Q10 is an electron transport chain component of the mitochondria, which assists proton and electron transfer across the inner mitochondrial membrane. Displays neuroprotective activity. Studies indicate that Coenzyme Q10 can protect human endothelial cells from oxidative damage by modulating the nitric oxide pathway. Component of the mitochondrial transporter chain that behaves as a powerful antioxidant. In addition, Coenzyme Q10 inhibits LDL oxidation, a major process in the development of atherosclerosis. Coenzyme Q10 is known to suppress the down regulation of NOS3 (endothelial nitric oxide synthase, eNOS) and up-regulation of NOS2 (inducible nitric oxide synthase, iNOS). As a result of its ability to bind Ca2+, Coenzyme Q10 can transport this cation across artificial biomimetic membranes.
Cell culture, transfection and drug treatment[1]
PC12 cells were grown in Dulbecco’smodified Eagle’s medium (DMEM) supplemented with 100μg/mL penicillin/streptomycin,2 mM L-glutamine, 10% fetal bovine serum and maintained at 37°C, 5% CO2 in a humidified incubator.
The expression vector pcDNA encoding human full-lengthATX3 was used for transfection. Constructs of normal ATX3 (pcDNA3-myc-ATX3-Q28)and expanded ATX3 (pcDNA3-myc-ATX3-Q84).
For transient transfections, cells were seededon 6-well plates and grown to 60–80% confluence for 16 h. For each well, cellswere exposed for 5 h to a mixture of 10μLLipofectAMINE 2000 Reagentt and 2μg of plasmid DNA in OptiMEM. Then,the culture medium was replaced by complete medium containing distinct drugs.Cells were incubated for another 48 h and examined. Drug treatments included 2.5,5 or 7.5 mM lithium carbonate and 10, 30, or 90μM coenzymeQ10.
Cellviability and apoptosis
Cell viability was evaluated by the MTT,3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium assay. After 48 h of drugtreatment, the medium was replaced, MTT was added to the DMEM (0.3 mg/mL)followed by a 4-h incubation. Next, cells were washed with PBS, dye crystalswere dissolved in DMSO and the absorbance measured at 570 nm.
Apoptotic cells were detected using theApoTargett Annexin-V FITC Apoptosis Kit, which employs a fluorescein-labeledAnnexin-V in concert with propidium iodide (PI), following manufacturer’s recommendation.Samples were analyzed on a FACScalibur flow cytometer. For each sample, aminimum of 10,000 events were collected and analyzed using CELLQuest software. ThePI results were used to exclude necrotic cells from the evaluation ofapoptosis.
Animails[2]
The study was performed on 84 С57Вlmale mice weighting 22.4 ± 1.12 g bred in animal facility
Materialsand admonitions
Lewis lung carcinoma (LLC) was used as atumor model. LLC cells (5 x 105 cells per animal) were transplantedsubcutaneously. The compounds (L-Arginine hydrocloride (L-Arg), CoQ10) wereadministered intraperitoneally daily for 10 days at low or high doses: LArg- 60and 360 mg/kg body weight; CoQ10- 0.2 and1.2 mg/kg body weight.
Experiments
The animals were distributed into 8experimental groups; І — intact animals (n = 10); ІІ — tumor control (n = 11);ІІІ and ІV — animals with tumors treated with high (n = 12) and low (n = 10) dosesof L-Arg, respectively; V та VІ — animals with tumors treated with high (n =10) and low (n = 10) doses of СоQ10, respectively; VІІ and VІІІ — animals withtumors treated with high (n = 10) and low (n = 10) doses of L-Arg and СоQ10, respectively. Animals of group II received dailyintraperitoneal injections of physiological saline at corresponding volume for10 days and served as a positive control.
The research of the electron transportchain in mitochondria, СоQ10 levels in mitochondria and free iron (FI) in tumorcells was performed by electron paramagnetic resonance (EPR) method withcomputerized spectrometer RE-1307 using the technology of low-temperature stabilizationof biological material (77 K). The rate of superoxide radical generation bymitochondria of cells was determined by EPR method using a spin trap(2,2,6,6,-tetrametyl-4-oxypiperidine) at the room temperature in a specialparamagnetic pure quartz cuvette. The level of NO in the tumor tissue wasinvestigated by EPR using the Spin Traps technology (spin trap-diethyldithiocarbamates) at the temperature of 77 K.
The activity of MMP-2 and -9 in tumortissue was determined by zymography method in polyacrylamide gel (with additionof gelatin as a substrate) based on SDS-electrophoresis of proteins. The tumorvolume was determined by the formula 1: V = (π/6) · D1 · D2 · D3, (1) where V —tumor volume (mm3); D1, D2, D3 — tumor length, width, and height. The number ofmetastases was counted, and their volume — by the formula 1. The antitumoractivity of the studied compounds was evaluated by tumor growth inhibition: G%= (vc−ve)/mk · 100%, (2) where G% — percentage of tumor growth inhibition byvolume; vc — average tumor volume in the control; ve — average tumor volume inthe study group.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Lopes-Ramos CM, Pereira TC, Dogini DB, Gilioli R, Lopes-Cendes I. Lithium carbonate and coenzyme Q10 reduce cell death in a cell model of Machado-Joseph disease. Braz J Med Biol Res. 2016;49(12):e5805.
[2] Burlaka AP GI, Golotiuk VV, Vovk AV, Lukin SМ. Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10. Exp Oncol. 2016;38(1):31-35.
分子式 C59H90O4 |
分子量 863.34 |
CAS号 303-98-0 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO <1 mg/mL |
Water <1 mg/mL |
Ethanol 5 mM |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00720369 | Bipolar Depression | Drug: CoEnzyme Q10 | Mclean Hospital|National Alliance for Research on Schizophrenia and Depression | 2008-07-01 | 2013-11-26 | |
NCT00541164 | Charcot Marie Tooth Disease | Drug: Coenzyme Q10|Dietary Supplement: Coenzyme Q10 | Memorial Medical Center|United States Department of Defense | Phase 1|Phase 2 | 2007-09-01 | 2013-07-11 |
NCT01048385 | Aneuploidy|Pregnancy|Miscarriage | Dietary Supplement: Coenzyme Q10 concomitant treatment|Dietary Supplement: Placebo | University of Toronto|Ferring Pharmaceuticals | 2009-12-01 | 2014-09-05 | |
NCT00096356 | Breast Cancer|Fatigue | Dietary Supplement: CoQ10 & Vitamin E|Dietary Supplement: Placebo & Vitamin E | Wake Forest University Health Sciences|National Cancer Institute (NCI) | 2004-08-01 | 2017-01-18 | |
NCT01026311 | Muscle Weakness|Myalgia|Side Effects of Statins | Drug: Coenzyme q 10|Drug: placebo | Richard Deichmann, MD|Ochsner Health System | Phase 4 | 2009-11-01 | 2012-05-01 |
NCT01140308 | Statin Myopathy | Drug: CoEnzyme Q10|Drug: Placebo | Hartford Hospital | 2009-09-01 | 2012-09-06 | |
NCT00878124 | Poor Ovarian Response | Dietary Supplement: Coenzyme Q10 co treatment|Other: Placebo Caps | University of Toronto|Toronto Centre for Advanced Reproductive Technology|Ferring Pharmaceuticals | 2009-06-01 | 2010-01-11 | |
NCT01390389 | Bipolar Depression | Drug: Coenzyme Q10 | Mclean Hospital|National Institute of Mental Health (NIMH) | 2011-07-01 | 2013-10-30 | |
NCT02415114 | CoQ10 Blood Levels|CoQ10 Blood Levels With Statin Use | Dietary Supplement: Omega Q Plus Resveratrol (with 50mg CoQ10) | KGK Synergize Inc.|Healthy Directions, LLC | Phase 1 | 2015-03-01 | 2015-09-22 |
NCT00740714 | Parkinson Disease | Drug: Coenzyme Q10 with vitamin E|Drug: placebo with vitamin E | Weill Medical College of Cornell University|National Institute of Neurological Disorders and Stroke (NINDS)|University of Rochester | Phase 3 | 2008-12-01 | 2012-12-24 |
NCT02315651 | Attention Deficit Hyperactivity Disorder | Dietary Supplement: Coenzyme Q10|Dietary Supplement: Placebo | Rabin Medical Center|Hebrew University of Jerusalem | 2015-01-01 | 2014-12-11 | |
NCT00957216 | Sporadic Ataxia | Drug: Placebo (sugar pill)|Drug: Coenzyme Q10 | The University of Texas Medical Branch, Galveston|University of Florida | Phase 1 | 2008-04-01 | 2010-04-15 |
NCT01910766 | Polycystic Ovary Syndrome | Drug: Coenzyme Q10|Drug: clomiphene citrate | Mansoura University | 2010-01-01 | 2013-07-29 | |
NCT01319110 | Cardiac Arrest|Sudden Cardiac Arrest | Drug: Coenzyme Q10|Dietary Supplement: Placebo | Beth Israel Deaconess Medical Center | Phase 2 | 2011-02-01 | 2017-03-03 |
NCT00920699 | Huntington's Disease | Drug: CoQ10 | Huntington Study Group|National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 | 2010-02-01 | 2012-03-28 |
NCT02251626 | Burn Injury | Dietary Supplement: coenzyme Q10|Dietary Supplement: Placebo | Massachusetts General Hospital|Kaneka Pharma America LLC | Early Phase 1 | 2014-04-01 | 2016-09-13 |
NCT00997269 | Pain|Soreness|Weakness|Fatigue | Dietary Supplement: Co-enzyme Q-10|Dietary Supplement: Placebo | Stony Brook University | 2009-09-01 | 2016-04-28 | |
NCT01892176 | Parkinson Disease | Dietary Supplement: coenzyme q10 | National University Hospital, Singapore | Phase 2|Phase 3 | 2012-06-01 | 2013-07-08 |
NCT00976131 | Breast Cancer | Drug: Coenzyme Q10|Other: Coenzyme Q10 Placebo | Heather Greenlee|National Institutes of Health (NIH)|Columbia University | Phase 1 | 2009-09-01 | 2016-05-19 |
NCT01148836 | Pulmonary Arterial Hypertension | Dietary Supplement: Coenzyme Q-10 in Pulmonary Hypertension subjects|Dietary Supplement: Coenzyme Q-10 in Normal Control subjects | The Cleveland Clinic | 2010-01-01 | 2015-03-19 | |
NCT01408680 | Oxidative Stress|Inflammation|Endothelial Dysfunction | Dietary Supplement: Coenzyme Q10|Dietary Supplement: Coenzyme Q10|Dietary Supplement: Placebo | University of Washington|National Center for Complementary and Integrative Health (NCCIH) | 2011-11-01 | 2014-12-02 | |
NCT00716612 | Statin Induced Myalgia | Drug: Coenzyme Q 10|Drug: Placebo control | Hadassah Medical Organization | 2009-01-01 | 2013-01-24 | |
NCT00608881 | Huntington's Disease | Drug: coenzyme Q10|Other: placebo | Massachusetts General Hospital|National Institute of Neurological Disorders and Stroke (NINDS)|University of Rochester | Phase 3 | 2008-03-01 | 2016-02-29 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们